Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.

Mantovani, Giovanni; Macciò, Antonio; Madeddu, Clelia; Serpe, Roberto; Massa, Elena; Dessì, Mariele; Panzone, Filomena; Contu, Paolo

Mantovani, Giovanni; Macciò, Antonio; Madeddu, Clelia; Serpe, Roberto; Massa, Elena; Dessì, Mariele; Panzone, Filomena; Contu, Paolo.

Affiliation

Mantovani G; Department of Medical Oncology,University of Cagliari, Cagliari, Italy. mantovan@medicina.unica.it

Oncologist ; 15(2): 200-11, 2010.

Article in En | MEDLINE | ID: mdl-20156909

Subject(s)

Cachexia/drug therapy; Carnitine/therapeutic use; Eicosapentaenoic Acid/therapeutic use; Medroxyprogesterone/therapeutic use; Megestrol Acetate/therapeutic use; Neoplasms/complications; Thalidomide/therapeutic use; Appetite Stimulants/adverse effects; Appetite Stimulants/therapeutic use; Cachexia/etiology; Cachexia/metabolism; Carnitine/adverse effects; Eicosapentaenoic Acid/adverse effects; Female; Humans; Interleukin-6/metabolism; Male; Medroxyprogesterone/adverse effects; Megestrol Acetate/adverse effects; Middle Aged; Neoplasms/metabolism; Thalidomide/adverse effects; Vitamin B Complex/adverse effects; Vitamin B Complex/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Cachexia / Carnitine / Eicosapentaenoic Acid / Megestrol Acetate / Medroxyprogesterone / Neoplasms Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2010 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google